Articles in this section

Quality & Compliance (CFR Part 11)

Summary

CFR Part 11 defines when electronic records and electronic signatures are legally equivalent to paper in FDA-regulated industries. It exists to ensure that digital records are trustworthy, traceable, and cannot be altered without detection.


WHAT THIS IS

  • CFR Part 11 is a U.S. regulation that sets the requirements for using electronic records and electronic signatures in regulated environments such as pharmaceuticals, food production, and medical devices.
     
  • The regulation ensures that digital systems can replace paper-based processes, but only if they guarantee data integrity, user accountability, and traceability.
     
  • To meet these requirements, systems must include mechanisms such as secure electronic signatures, audit trails, access control, and traceable records.
     

WHY IT MATTERS

  • Regulated manufacturers must prove that every critical activity was performed correctly, by the right person, at the right time.
     
  • Without compliant systems, digital records cannot be trusted or accepted during audits, forcing companies to rely on inefficient paper processes.
     
  • CFR Part 11 enables companies to digitize operations while maintaining legal validity, reducing administrative burden, and making audit preparation faster and more reliable.
     

WHEN YOU WOULD USE THIS

  • Use this when:
    • You operate in an FDA-regulated industry
    • You want to replace paper-based documentation with digital systems
    • You need to ensure records are legally valid and audit-ready
    • You must prove data integrity and user accountability across operations
       

HOW IT WORKS

  • The regulation requires that every electronic record is secure, traceable, and resistant to tampering.
     
  • Electronic signatures must be uniquely linked to an individual and require authentication (such as a password or PIN), ensuring that no one can sign on behalf of someone else.
     
  • Audit trails automatically record all actions taken on a record, including who performed them and when, creating a complete and time-stamped history.
     
  • Access control restricts who can create, modify, or sign records, ensuring only authorized personnel can perform critical actions.
     
  • Traceable records and versioning ensure that any changes are recorded rather than overwritten, making it possible to see the full history of a record.
     
  • Together, these elements ensure that electronic records are trustworthy, verifiable, and defensible during audits.

    digital level_0f1f71.png
     

KEY TERMS / COMPONENTS

  • CFR Part 11:
    • A U.S. FDA regulation defining requirements for electronic records and electronic signatures
       
  • Electronic Signature:
    • A digitally verified confirmation linked to a specific user and record
       
  • Audit Trail:
    • A time-stamped log of all actions taken on a record
       
  • Access Control:
    • Mechanisms that ensure only authorized users can perform specific actions
       
  • Traceable Records:
    • Records where all changes and versions are preserved and visible
       
  • Data Integrity:
    • Assurance that data is accurate, complete, and cannot be altered without detection
       
  • GMP guidelines:
    • This has the same core principles as CFR Part 11: unique signatures, tamper-evident records, and a complete audit trail. This is more relevant If your based in Europe, and Factbird is compliant in this.
       


COMMON MISUNDERSTANDINGS

  • “CFR Part 11 is only about electronic signatures.”
    • It also requires audit trails, access control, and full data traceability
       
  • “Any digital system is compliant by default.”
    • Systems must be specifically designed to meet strict requirements for security and traceability
       
  • “Compliance is only relevant during audits.”
    • Compliance must be maintained continuously, not just when audits occur
       
  • “This only applies in the US.”
    • While it is a U.S. regulation, similar principles are required in Europe under GMP guidelines

       

 

 

 

 

 







 


 


 

 

 

 

Was this article helpful?
0 out of 0 found this helpful